NCT04606589View on ClinicalTrials.gov

Feasibility Study Evaluating the Efficacy of a Wireless Vital Signs Monitor for Critically Ill Newborns in Kenya

EARLY_PHASE1CompletedINTERVENTIONAL

Enrollment

167

Participants

Timeline

Start Date

February 1, 2021

Primary Completion Date

May 30, 2021

Study Completion Date

May 30, 2021

Conditions

Newborn MorbidityNewborn Complication

Interventions

DEVICE

neoGuard vital signs monitor

The neoGuardTM device is a 4-in-1 wearable vital signs monitor designed to continuously measure temperature, pulse rate, respiratory rate and blood oxygen saturation in newborns.

Trial Locations (1)

Unknown

Kakamega County Referral Hospital, Kakamega

All Listed Sponsors

collaborator

Center for Public Health and Development

UNKNOWN

lead

Neopenda, PBC

INDUSTRY

NCT04606589 - Feasibility Study Evaluating the Efficacy of a Wireless Vital Signs Monitor for Critically Ill Newborns in Kenya | Biotech Hunter | Biotech Hunter